EAN News

When the EAN was founded in 2014, the 1st EAN President Günther Deuschl decided that we should have an EAN archive. He invited two members of the mother societies ENS and EFNS to volunteer as “historians” and become the first… Continue Reading

EAN Programme Committee Chair, Irena Rektorová, & EAN President, Elena Moro preview some major highlights of the EAN Congress 2025, taking place in Helsinki in just a few weeks.

Welcome to the June 2025 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions!

Our papers of the month for June are two studies that suggest that transplantation of dopaminergic progenitor cells into the striatum may confer meaningful clinical benefits for patients with Parkinson’s disease.

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for May 2025.

Together with the Brain Health Mission, the EAN is excited to announce the launch of the Public Brain Health Day, on Monday, 23 June 2025, during the 11th EAN Congress in Helsinki.

The University of Cyprus in Nicosia was thrilled to host the highly anticipated 9th European Sleep Foundation (ESF) Sleep Medicine School from 31 March to 3 April 2025, endorsed by the EAN.

EAN Scientific Committee Chair, Gereon R. Fink, provides a look at various ongoing projects, including a variety of ways you can contribute to EAN scientific activities.

Welcome to the May 2025 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions!

Our papers of the month for May are two papers present findings from recent trials evaluating the efficacy and safety of tolebrutinib in patients with multiple sclerosis.

The Innovative Health Initiative (IHI) has just published draft topic texts for its upcoming Call 11, expected to launch officially in late June 2025.

The EAN was asked by a media outlet to provide comment on the possible role of creatine in the prevention of Alzheimer’s disease, the subject of much recent internet speculation.

Following an earlier decision by the EMA, the EU Commission has granted EU authorisation for Lecanemab to treat mild cognitive impairment in the early stages of Alzheimer’s disease.

We are immensely proud to announce that the 10th Congress of the European Academy of Neurology, held at the Messukeskus, Helsinki, in 2024, has been named Best Corporate Event Subject to a Fee at the 2024 Evento Awards, a Finnish event industry award that recognises the best events, venues, speakers, creators and companies in Finland.

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for April 2025.